A newer immune-suppressing drug called mycophenolate mofetil (CellCept) is better at controlling a serious kidney complication from lupus than another commonly used therapy, a new study suggests.
Full story | New England Journal of Medicine study
Watch this slide presentation to understand more about how the Affordable Care Act will affect people with lupus, and how you can make a difference.
Text LUPUS to 50555 to donate $10 to research. Or text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and data rates may apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms
Learn about local news and events from the LRI National Coalition.
Visit LupusTrials.org learn about lupus clinical trials that might be right for you or a family member.